Transgender men, pregnancy, and the "new" advanced paternal age: A review of the literature.


Journal

Maturitas
ISSN: 1873-4111
Titre abrégé: Maturitas
Pays: Ireland
ID NLM: 7807333

Informations de publication

Date de publication:
Oct 2019
Historique:
received: 13 06 2019
revised: 28 06 2019
accepted: 05 07 2019
entrez: 29 9 2019
pubmed: 29 9 2019
medline: 27 12 2019
Statut: ppublish

Résumé

Transgender men are assigned female at birth, but self-identify as male. Although some transgender men undergo gender-affirming hormonal treatment and/or surgery that preclude pregnancy, many (if not most) retain their female reproductive organs and, as a result, their capacity to become pregnant. Although the visibility of the transgender community has increased, the exposure of healthcare providers to transgender individuals, especially transgender men during pregnancy, as well as research that addresses evidence-based practice remain limited. In this review, we discuss obstetrical issues for transgender men who are ≥35 years old, termed the "new" advanced paternal age. We review preconception care and focus on fertility issues, the impact of stopping gender-affirming hormonal treatment, and age-appropriate health maintenance. We review antepartum and postpartum care, including labor and delivery, monitoring for perinatal depression, contraception, and chest feeding. Finally, we conclude with suggestions for areas for further research and study.

Identifiants

pubmed: 31561817
pii: S0378-5122(19)30584-5
doi: 10.1016/j.maturitas.2019.07.004
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

17-21

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Justin S Brandt (JS)

Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, United States; Gender Center of New Jersey, Rutgers Robert Wood Johnson University Hospital, New Brunswick, NJ, United States. Electronic address: jsb288@rwjms.rutgers.edu.

Amy J Patel (AJ)

Gender Center of New Jersey, Rutgers Robert Wood Johnson University Hospital, New Brunswick, NJ, United States; Department of Obstetrics, Gynecology, and Reproductive Sciences, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, United States.

Ian Marshall (I)

Gender Center of New Jersey, Rutgers Robert Wood Johnson University Hospital, New Brunswick, NJ, United States; Division of Pediatric Endocrinology, Department of Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, United States.

Gloria A Bachmann (GA)

Gender Center of New Jersey, Rutgers Robert Wood Johnson University Hospital, New Brunswick, NJ, United States; Department of Obstetrics, Gynecology, and Reproductive Sciences, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH